• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Halozyme Therapeutics, Inc. (HALO)

    -NasdaqGS
    18.41 Up 0.37(2.05%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Insider RosterGet Insider Roster for:
    Insider Holders*
    Individual/EntityMost Recent Trans.Shares Owned as of Trans. Date
    BIZZARI JEAN-PIERRE
    Director
    Acquisition (Non Open Market)
    May 6, 2015
    16,612
    May 6, 2015
    COUNTOURIOTIS ATHENA
    Officer
    Ownership Statement
    Jan 5, 2015
    0
    Jan 5, 2015
    ENGLER ROBERT
    Director
    Option Exercise
    Aug 14, 2014
    273,176
    Aug 14, 2014
    FALBERG KATHRYN E
    Director
    Acquisition (Non Open Market)
    May 6, 2015
    318,051
    May 6, 2015
    FROST GREGORY IAN
    Officer
    Option Exercise
    Dec 11, 2013
    3,641,380
    Dec 11, 2013
    KELLEY KENNETH J
    Director
    Sale
    Jun 18, 2015
    198,051
    Jun 18, 2015
    KIRK RANDAL J
    Director
    Acquisition (Non Open Market)
    May 6, 2015
    3,518,051
    May 6, 2015
    LIU JEAN I
    Officer
    Option Exercise
    Feb 4, 2014
    20,869
    Feb 4, 2014
    MATSUI CONNIE
    Director
    Acquisition (Non Open Market)
    May 6, 2015
    183,051
    May 6, 2015
    PATTON JOHN STUART
    Director
    Option Exercise
    Aug 19, 2014
    179,876
    Aug 19, 2014
    POSARD MATTHEW L.
    Director
    Acquisition (Non Open Market)
    May 6, 2015
    58,051
    May 6, 2015
    RAMSAY DAVID A
    Officer
    Disposition (Non Open Market)
    Feb 6, 2015
    364,320
    Feb 6, 2015
    SHAFFER JAMES P
    Officer
    Option Exercise
    Feb 4, 2014
    54,025
    Feb 4, 2014
    SHEPARD H. MICHAEL
    Officer
    Sale
    Aug 19, 2013
    13,198
    Aug 19, 2013
    TORLEY HELEN
    Officer
    Option Exercise
    Jan 6, 2015
    68,081
    Jan 6, 2015

    View Transactions for Insiders & Institutional Holders

     
    * Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.